Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care

preview_player
Показать описание
  1. PeerView CME
  2. CME
  3. meded
  4. neurology
  5. multiple sclerosis
  6. MS
Рекомендации по теме
Leveraging the Power 0:29:38

Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care

What are the 0:03:27

What are the benefits of adding anti-CD20 therapy to treatment with targeted agents in CLL?

ADI-001: anti-CD20 CAR-engineered 0:03:24

ADI-001: anti-CD20 CAR-engineered allogeneic γδ T cells in adults with B-cell malignancies

Determining the favorable 0:03:23

Determining the favorable clinical course in MS

#Alemtuzumab | Uses, 0:08:14

#Alemtuzumab | Uses, Dosage, Side Effects and Mechanism | Campath

Herpes Zoster. 0:03:36

Herpes Zoster.

Ublituximab: pending approval 0:01:41

Ublituximab: pending approval for relapsing MS

Understanding Multiple Sclerosis 0:02:10

Understanding Multiple Sclerosis | Dr. Rajiv Anand | BLK-Max Hospital, New Delhi

dkNET Webinar: Leveraging 0:54:27

dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabetes Risk and...05/19/2023

What is #Monkeypox| 0:07:27

What is #Monkeypox| How to treat #monkeypox| Answer all questions

Multiple Sclerosis and 0:01:56

Multiple Sclerosis and ACRM

Study design: How 0:39:50

Study design: How and when to use multiplexed immunofluorescence imaging in your research

Analytical Tools to 0:45:24

Analytical Tools to Evaluate CAR-T Cell Signaling & Activation

Edward Stack - 1:02:23

Edward Stack - Using multiplexed IHC to effectively navigate the hidden...

Oncology Product Launch 1:00:39

Oncology Product Launch – The Toolkit for Success_2020_09_23

New IBD Therapies 0:24:43

New IBD Therapies and Side Effects

Rheumatoid Arthritis & 0:03:51

Rheumatoid Arthritis & Physiotherapy

Mechanistic model-informed discovery 0:55:53

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology

Fine-Tuning the JAK/STAT 1:02:10

Fine-Tuning the JAK/STAT Pathway in Psoriasis

Unlock Spatial Biology 0:31:02

Unlock Spatial Biology with Orion Technology: Explore the possibilities

Establishing Efficacy with 0:59:34

Establishing Efficacy with Flow Cytometry- Based Receptor Occupancy Assays

Atara Biotherapeutics, Inc. 0:10:09

Atara Biotherapeutics, Inc. (NASDAQ: ATRA)

Understanding Natural Killer 0:20:14

Understanding Natural Killer Cells in Cancer Immunotherapies

Atara Biotherapeutics, Inc. 0:31:02

Atara Biotherapeutics, Inc. (NASDAQ: ATRA)